Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Response Quartile Analysis and the Predictive Value of Week 2 Early Response

Por Casey, Daniel E., Laubmeier, Kimberly K., Marler, Sabrina Vogel, Forbes, Robert A., Baker, Ross A.
Publicado em 2012

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning...

Por Clayton, Anita H, Baker, Ross A, Sheehan, John J, Cain, Zachary J, Forbes, Robert A, Marler, Sabrina Vogel, Marcus, Ronald, Berman, Robert M, Thase, Michael E
Publicado em 2014

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

Por Berman, Robert M, Thase, Michael E, Trivedi, Madhukar H, Hazel, James A, Marler, Sabrina Vogel, McQuade, Robert D, Carson, William, Baker, Ross A, Marcus, Ronald N
Publicado em 2011